Carlsberg A/S (CARL-B)
Copenhagen Exchange · Denmark · prices in DKK · close of 22 Oct 2026
Key indicators
| Last close | DKK 980.60 |
|---|---|
| 52-week range | 753.20 – 1,015.00 |
| Return, 1 month / 3 months | +13.1% / +4.5% |
| Return, 1 year / 3 years | +26.5% / +22.8% |
| Trend | Uptrend |
| RSI (14) | 80 |
| Volatility (1 year) | 23.9% |
| Worst drawdown (1 year) | -20.0% |
| Average daily value traded | 184.75M DKK |
| Dividend yield | 3.0% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Carlsberg is a Danish brewing company based in Copenhagen. It makes and sells beer and other beverages, including its namesake lager along with brands such as Tuborg, Kronenbourg and Somersby cider. Its customers are drinkers reached through retailers, bars, restaurants and distributors, and it operates breweries and sales operations in markets across Europe and Asia. The company also produces soft drinks and other non-alcoholic beverages alongside its beer portfolio.
The shares are listed on the Copenhagen Exchange in Denmark under the code CARL-B, and the price on this page is in Danish kroner (DKK). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Carlsberg A/S (CARL-B) trades on the Copenhagen Exchange in Denmark. It last closed at DKK 980.60 on 22 October 2026.
Its price-based Market X-Ray is 72 out of 100 (a strong price profile), ranking 27 of 164 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 26.5% and over the last three months it rose 4.5%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Copenhagen Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 69 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 12.0% | ||
| From 52-week high | -3.4% | ||
| Momentum | 71 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 4.5% | ||
| 6-month return | 19.7% | ||
| 12-month return, skipping the last month | 11.9% | ||
| Stability (higher is calmer) | 66 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 23.9% | ||
| Worst drawdown, 1 year (smaller is calmer) | -20.0% | ||
| Liquidity | 95 · Strong | Trades actively. | |
| Average daily value traded | 184.75M DKK | ||
| Zero-volume days | 0.0% | ||
| Income | 61 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 3.0% | ||
| Years with dividends | 5 |
Strengths
- Momentum: Rising faster than most stocks on this exchange.
- Liquidity: Trades actively.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | +5.1% |
|---|---|
| 1 month | +13.1% |
| 3 months | +4.5% |
| 6 months | +19.7% |
| 1 year | +26.5% |
| 3 years | +22.8% |
| 5 years | +7.2% |
Signals
| 50-day / 200-day average | 882.22 / 875.46 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 19.86 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 17 Mar 2026 | DKK 29.0000 |
| 18 Mar 2025 | DKK 27.0000 |
| 12 Mar 2024 | DKK 27.0000 |
| 14 Mar 2023 | DKK 27.0000 |
| 15 Mar 2022 | DKK 24.0000 |
| 16 Mar 2021 | DKK 22.0000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Copenhagen Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.